Table of Contents

1 Market Overview

• 1.1 Eculizumab Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Plasma Exchange
  • 1.2.2 Plasma Infusion
• 1.3 Market Analysis by Applications
  • 1.3.1 PNH
  • 1.3.2 aHUS
  • 1.3.3 Other
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Alexion
  • 2.1.1 Business Overview
  • 2.1.2 Eculizumab Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Alexion Eculizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Eculizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Eculizumab Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Eculizumab Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Eculizumab Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Eculizumab Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Eculizumab Market Analysis by Regions

• 4.1 Global Eculizumab Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Eculizumab Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Eculizumab Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Eculizumab Sales and Growth Rate (2014-2019)
• 4.3 Europe Eculizumab Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Eculizumab Sales and Growth Rate (2014-2019)
• 4.5 South America Eculizumab Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Eculizumab Sales and Growth Rate (2014-2019)

5 North America Eculizumab by Country

• 5.1 North America Eculizumab Sales, Revenue and Market Share by Country
  • 5.1.1 North America Eculizumab Sales and Market Share by Country (2014-2019)
  • 5.1.2 North America Eculizumab Revenue and Market Share by Country (2014-2019)
• 5.2 United States Eculizumab Sales and Growth Rate (2014-2019)
• 5.3 Canada Eculizumab Sales and Growth Rate (2014-2019)
• 5.4 Mexico Eculizumab Sales and Growth Rate (2014-2019)

6 Europe Eculizumab by Country

• 6.1 Europe Eculizumab Sales, Revenue and Market Share by Country
  • 6.1.1 Europe Eculizumab Sales and Market Share by Country (2014-2019)
  • 6.1.2 Europe Eculizumab Revenue and Market Share by Country (2014-2019)
• 6.2 Germany Eculizumab Sales and Growth Rate (2014-2019)
• 6.3 UK Eculizumab Sales and Growth Rate (2014-2019)
• 6.4 France Eculizumab Sales and Growth Rate (2014-2019)
• 6.5 Russia Eculizumab Sales and Growth Rate (2014-2019)
• 6.6 Italy Eculizumab Sales and Growth Rate (2014-2019)

7 Asia-Pacific Eculizumab by Country

• 7.1 Asia-Pacific Eculizumab Sales, Revenue and Market Share by Country
  • 7.1.1 Asia-Pacific Eculizumab Sales and Market Share by Country (2014-2019)
  • 7.1.2 Asia-Pacific Eculizumab Revenue and Market Share by Country (2014-2019)
• 7.2 China Eculizumab Sales and Growth Rate (2014-2019)
• 7.3 Japan Eculizumab Sales and Growth Rate (2014-2019)
• 7.4 Korea Eculizumab Sales and Growth Rate (2014-2019)
• 7.5 India Eculizumab Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Eculizumab Sales and Growth Rate (2014-2019)

8 South America Eculizumab by Country

• 8.1 South America Eculizumab Sales, Revenue and Market Share by Country
  • 8.1.1 South America Eculizumab Sales and Market Share by Country (2014-2019)
  • 8.1.2 South America Eculizumab Revenue and Market Share by Country (2014-2019)
• 8.2 Brazil Eculizumab Sales and Growth Rate (2014-2019)
• 8.3 Argentina Eculizumab Sales and Growth Rate (2014-2019)
• 8.4 Colombia Eculizumab Sales and Growth Rate (2014-2019)

9 Middle East and Africa Eculizumab by Countries

• 9.1 Middle East and Africa Eculizumab Sales, Revenue and Market Share by Country
  • 9.1.1 Middle East and Africa Eculizumab Sales and Market Share by Country (2014-2019)
  • 9.1.2 Middle East and Africa Eculizumab Revenue and Market Share by Country (2014-2019)
• 9.2 Saudi Arabia Eculizumab Sales and Growth Rate (2014-2019)
• 9.3 Turkey Eculizumab Sales and Growth Rate (2014-2019)
• 9.4 Egypt Eculizumab Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Eculizumab Sales and Growth Rate (2014-2019)
• 9.6 South Africa Eculizumab Sales and Growth Rate (2014-2019)

10 Global Eculizumab Market Segment by Type

• 10.1 Global Eculizumab Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Eculizumab Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Eculizumab Revenue and Market Share by Type (2014-2019)
• 10.2 Plasma Exchange Sales Growth and Price
  • 10.2.1 Global Plasma Exchange Sales Growth (2014-2019)
  • 10.2.2 Global Plasma Exchange Price (2014-2019)
• 10.3 Plasma Infusion Sales Growth and Price
  • 10.3.1 Global Plasma Infusion Sales Growth (2014-2019)
  • 10.3.2 Global Plasma Infusion Price (2014-2019)

11 Global Eculizumab Market Segment by Application

• 11.1 Global Eculizumab Sales Market Share by Application (2014-2019)
• 11.2 PNH Sales Growth (2014-2019)
• 11.3 aHUS Sales Growth (2014-2019)
• 11.4 Other Sales Growth (2014-2019)

12 Eculizumab Market Forecast (2019-2024)

• 12.1 Global Eculizumab Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Eculizumab Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Eculizumab Market Forecast (2019-2024)
  • 12.2.2 Europe Eculizumab Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Eculizumab Market Forecast (2019-2024)
  • 12.2.4 South America Eculizumab Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Eculizumab Market Forecast (2019-2024)
• 12.3 Eculizumab Market Forecast by Type (2019-2024)
  • 12.3.1 Global Eculizumab Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Eculizumab Market Share Forecast by Type (2019-2024)
• 12.4 Eculizumab Market Forecast by Application (2019-2024)
  • 12.4.1 Global Eculizumab Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Eculizumab Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology

Scope of the Report:
The worldwide market for Eculizumab is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Eculizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Alexion

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Plasma Exchange
Plasma Infusion

Market Segment by Applications, can be divided into
PNH
aHUS
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eculizumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Eculizumab, with price, sales, revenue and global market share of Eculizumab in 2017 and 2018.
Chapter 3, the Eculizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eculizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Eculizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Eculizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.